| Literature DB >> 34084672 |
Shabbir Hussain1, Abdul Hafeez1, Hira Nazim1, Rahim Gohar2, Muhammad Jawaid Mallick1.
Abstract
BACKGROUND: Planning craniospinal irradiation (CSI) with ''field-in-field'' (FIF) homogenization technique in combination with daily, intrafractional modulation of the field junctions is needed to avoid spinal cord overdose. Photon-based techniques for CSI may result in dose inhomogeneity within the treatment volume and usually require a weekly manual shift of the field junctions to minimize the possibility of spinal cord overdose. Nowadays, FIF technique is used to feather out the dose inhomogeneity caused by multiple fields. We have started using this technique after acquiring advanced technology machines in recent years. METHODS AND MATERIALS: Sixteen patients treated with three-dimensional conformal radiation therapy (3D-CRT) for CSI were retrospectively chosen for analysis. These patients were treated during 2019-2020. Contouring of planning target volume (PTV) and organs at risk (OAR) was done, and planning was done on Varian EclipseTM Treatment Planning System (TPS) (Varian Medical Systems, Palo Alto, CA). These patients were planned with lateral craniocervical fields and posterior spinal fields using a forward-planned FIF technique. Field junctions were automatically modulated and custom-weighted for maximal homogeneity within each treatment fraction. Dose-volume histogram (DVH) was used for analysis of results. A corresponding plan without FIF technique was planned; then maximum dose at the junction was noted for each patient with both plans, and the readings were evaluated. Paired sample t-test was used to compute the p-values for the inferential statistics.Entities:
Keywords: 3d-crt; craniospinal irradiation (csi); field-in-field technique; medulloblastoma
Year: 2021 PMID: 34084672 PMCID: PMC8164000 DOI: 10.7759/cureus.14744
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1Comparison of two plans of a medulloblastoma child patient with and without field-in-field technique and modulated junctions
A: Sagittal DRR of a medulloblastoma child planned without field-in-field technique. Note the junction of the craniocervical field with the PA field showing deficient coverage of the anterior area of the PTV with 95% coverage (shown in green lines) of the prescribed radiation dose and the subsequent hot spot areas showed with purple-colored dose distribution areas.
B: Sagittal CT images of the same patient planned with field-in-field technique and modulated junctions, and dose coverage is showed in color wash. The junction can now be seen covered with ≥95% coverage of the prescribed dose with minimum hot spot areas.
DRR, Digitally reconstructed radiograph; PA, posteroanterior; PTV, planning target volume.
Figure 2Comparison of DVH of the same patient planned with and without FIF technique
The graph shows two curves, one without FIF technique and modulated junction of which the curves show deficient 95% coverage and along with that more hot spot. In contrast, the second curve with the FIF technique shows good 95% coverage with lesser hot areas.
DVH, Dose-volume histogram; FIF, field-in-field.
Dose to thecal sac evaluated with and without FIF technique and modulated junction shifts
This table shows the dose at the thecal sac with and without FIF technique, and it proves that with field-in-field technique and modulated junctions, doses ≥110% and ≥120% are recorded very much less to the thecal sac as compared to non-FIF technique.
FIF, Field-in-field.
| S. No. | Patient Diagnosis | Volume of Thecal Sac at ≥100%, ≥110%, and ≥120% of the Prescribed Dose | |||||
| Without FIF Technique | With FIF Technique | ||||||
| ≥100% | ≥110% | ≥120% | ≥100% | ≥110% | ≥120% | ||
| 1. | Medulloblastoma | 99 | 71 | 16 | 98 | 18 | 0 |
| 2. | Medulloblastoma | 99 | 68 | 21 | 99 | 15 | 0 |
| 3. | Medulloblastoma | 98 | 72 | 6 | 99 | 15 | 0 |
| 4. | Atypical teratoid rhabdoid tumor | 99 | 74 | 15 | 97 | 10 | 0 |
| 5. | Medulloblastoma | 97 | 73 | 25 | 99 | 11 | 0 |
| 6. | Medulloblastoma | 99 | 55 | 10 | 97 | 6 | 1 |
| 7. | Medulloblastoma | 98 | 71 | 20 | 99 | 10 | 0 |
| 8. | Germ cell tumor brain (germinoma) | 99 | 69 | 26 | 97 | 15 | 2 |
| 9. | Medulloblastoma | 99 | 68 | 28 | 99 | 5 | 0 |
| 10. | Medulloblastoma | 98 | 67 | 18 | 98 | 2 | 0 |
| 11. | Medulloblastoma | 97 | 54 | 27 | 99 | 11 | 0 |
| 12. | Medulloblastoma | 98 | 40 | 19 | 98 | 9 | 0 |
| 13. | Medulloblastoma | 99 | 65 | 15 | 99 | 12 | 1 |
| 14. | Medulloblastoma | 97 | 39 | 8 | 97 | 14 | 0 |
| 15. | Medulloblastoma | 98 | 45 | 12 | 96 | 13 | 0 |
| 16. | Medulloblastoma | 99 | 63 | 17 | 99 | 10 | 1 |
Comparison of means and p-value calculation with and without FIF technique and modulated junction shifts
FIF, Field-in-field.
| Volume of Thecal Sac at ≥100%, ≥110%, and ≥120% of the Prescribed Dose | Mean Scores | P-Value |
| ≥100% (without FIF technique) | 98.31 | 0.580 |
| ≥100% (with FIF technique) | 98.12 | |
| ≥110% (without FIF technique) | 62.12 | <0.0001 |
| ≥110% (with FIF technique) | 11.00 | |
| ≥120% (without FIF technique) | 17.69 | <0.0001 |
| ≥120% (with FIF technique) | 0.31 |